Perceptions About Asymptomatic Hyperuricemia and Views About Urate‐Lowering Therapy in People With Asymptomatic Hyperuricemia

Most participants perceived minimal consequences of asymptomatic hyperuricemia. Hyperuricemia was not well understood by participants, and biologic causes were generally underrecognized. Despite a range of concerns about hyperuricemia-associated conditions, particularly kidney disease and cardiovascular disease, a urate-lowering medication for asymptomatic hyperuricemia was not considered necessary, which aligns with most current management guidelines.

Authors

Institutions

Publication Details

Journal
Arthritis Care & Research
Published
2025-08-30
DOI
https://doi.org/10.1002/acr.25639
Citations
1
Primary Topic
Gout, Hyperuricemia, Uric Acid
Type
article
Field-Weighted Citation Impact
1.43

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Perceptions About Asymptomatic Hyperuricemia and Views About Urate‐Lowering Therapy in People With Asymptomatic Hyperuricemia

Mariano Andrés, Tristan Pascart, Borislav Mihov, Tony Raymond Merriman et al.
1 citations
Arthritis Care & Research
Gout, Hyperuricemia, Uric Acid
1.43
article

Perceptions About Asymptomatic Hyperuricemia and Views About Urate‐Lowering Therapy in People With Asymptomatic Hyperuricemia

Mariano Andrés, Tristan Pascart, Borislav Mihov, Tony Raymond Merriman, Janitzia Vázquez Mellado, Greg D. Gamble, Eleonora Norkuvienė, Till Uhlig, Tuhina Neogi, Janine Haslett, María-Luisa Peral-Garrido, Anne Horne, Lisa K. Stamp, Keith J. Petrie, Sarah Stewart, Nicola Dalbeth, Mingshu Sun, Adwoa Dansoa Tabi‐Amponsah, William J. Taylor, Changgui Li
article en
1 citations

Abstract

Most participants perceived minimal consequences of asymptomatic hyperuricemia. Hyperuricemia was not well understood by participants, and biologic causes were generally underrecognized. Despite a range of concerns about hyperuricemia-associated conditions, particularly kidney disease and cardiovascular disease, a urate-lowering medication for asymptomatic hyperuricemia was not considered necessary, which aligns with most current management guidelines.

Arthritis Care & ResearchVol. 78(3)
Qingdao University (CN), Boston University (US), Lithuanian University of Health Sciences (LT), Qingdao Agricultural University (CN), University of Auckland (NZ), Université Catholique de Lille (FR), Hospital General de México (MX), Dunedin Public Hospital (NZ), University of Alabama at Birmingham (US), New Zealand Brain Research Institute (NZ), Diakonhjemmet Hospital (NO), Hospital Universitario del Vinalopó (ES), Hospital General Universitario de Alicante Doctor Balmis (ES), Qingdao Center of Resource Chemistry and New Materials (CN), University of Otago (NZ)
Amgen, Horizon Pharmaceuticals, Auckland Medical Research Foundation, University of Auckland, National Institutes of Health, Health Research Council of New Zealand, National Key Research and Development Program of China
Openalex Percentile: Top 16%
Gout, Hyperuricemia, Uric Acid
1.43
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.